Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertagen vs Boostrix in Adolescents
NCT02946190Phase 2Completed
- Start
- Oct 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of paracetamol + caffeine in pertussis (2 arms). Primary endpoint: Geometric Mean Concentration of neutralizing antibodies to Pertussis Toxin at 28 days. Started Oct 2016; status: completed.
02
Drugs
paracetamol + caffeine
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT02946190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02946190.